← Alle mensen

JS

Jin-Yuan Shih

7 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Sequentieel afatinib en osimertinib versus afatinib en chemotherapie bij EGFR-gemuteerd NSCLC: Taiwanese data

Targeted oncology · 20 maart 2026

Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Gevorderd NSCLC: The COC...

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-10

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 september 2025

RELAY: Final Totale overleving for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-04

Upfront liquid biopsy NGS bij onbehandeld gevorderd NSCLC: BFAST fase II/III

European journal of cancer (Oxford, England : 1990) · 2023-11

RELAY subgroepanalyse naar EGFR-mutatietype: ramucirumab plus erlotinib bij NSCLC

Clinical cancer research : an official journal of the American Association for Cancer Research · 1 oktober 2021

Ramucirumab plus erlotinib bij onbehandeld EGFR-gemuteerd NSCLC: RELAY fase III

The Lancet. Oncology · 2019-12